Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often highlight the possibility for substantial therapeutic outcomes, particularly in conditions where conventional treatments have proven limited. However, crucially important to assess the considerable financial burden associated with